MALVERN, Pa., March 25, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), a leading remote medical technology company focused on the delivery of health information to improve quality of life ...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced new research evaluating mobile cardiac outpatient telemetry (MCOT) as a ...

CONSHOHOCKEN, Pa.--CardioNet, Inc. (NASDAQ:BEAT) today announced the availability of new, innovative clinical and reporting enhancements to the Company's existing Mobile Cardiac Outpatient Telemetry ...

CardioNet, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on diagnosing and monitoring cardiac arrhythmias, announced today the release of a new application for the iPad, ...

February 2, 2012 (New Orleans, Louisiana) — Outpatient cardiac telemetry over 21 days detects occult paroxysmal atrial fibrillation (PAF) in almost 20% of patients with cryptogenic cerebral ischemia, ...

New Orleans, LA - Outpatient cardiac telemetry over 21 days detects occult paroxysmal atrial fibrillation (AF) in almost 20% of patients with cryptogenic cerebral ischemia, a new study shows [1].

CardioNet said Wednesday that it has launched an updated version of its Mobile Cardiac Outpatient Telemetry, or MCOT, device. The new product costs one-third less to make and “will enable physicians ...

MALVERN, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life ...